{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T17:58:58Z","timestamp":1784224738921,"version":"3.55.0"},"reference-count":80,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Experimental Medicine Research Center, Tehran University of Medical Sciences, Tehran, Iran","award":["94-04-158-31015"],"award-info":[{"award-number":["94-04-158-31015"]}]},{"DOI":"10.13039\/501100003968","name":"Iran National Science Foundation (INSF)","doi-asserted-by":"publisher","award":["96002757"],"award-info":[{"award-number":["96002757"]}],"id":[{"id":"10.13039\/501100003968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacological Reports"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.pharep.2018.05.004","type":"journal-article","created":{"date-parts":[[2018,5,13]],"date-time":"2018-05-13T16:57:06Z","timestamp":1526230626000},"page":"1015-1022","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["The role of nitric oxide\u2013cGMP pathway in selegiline antidepressant-like effect in the mice forced swim test"],"prefix":"10.1007","volume":"70","author":[{"given":"Sattar","family":"Ostadhadi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0942-9351","authenticated-orcid":false,"given":"Saeed","family":"Shakiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Norouzi-Javidan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahid","family":"Nikoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samira","family":"Zolfaghari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohsen","family":"Chamanara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad-Reza","family":"Dehpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"10.1016\/j.pharep.2018.05.004_bib0005","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/0165-6147(94)90315-8","article-title":"Current advances and trends in the treatment of depression","volume":"15","author":"Blier","year":"1994","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.pharep.2018.05.004_bib0010","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1001\/archpsyc.64.3.327","article-title":"The role of dopamine in the pathophysiology of depression","volume":"64","author":"Dunlop","year":"2007","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharep.2018.05.004_bib0015","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/S0014-2999(00)00566-5","article-title":"The role of dopamine in the mechanism of action of antidepressant drugs","volume":"405","author":"D'Aquila","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharep.2018.05.004_bib0020","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0925-4927(99)00009-8","article-title":"Gaebel W: Dopamine D 2 receptor binding before and after treatment of major depression measured by [123 I] IBZM SPECT","volume":"90","author":"Klimke","year":"1999","journal-title":"Psychiatry Res: Neuroimaging"},{"key":"10.1016\/j.pharep.2018.05.004_bib0025","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/bmb\/ldn013","article-title":"A review of Parkinson's disease","volume":"86","author":"Davie","year":"2008","journal-title":"Br Med Bull"},{"key":"10.1016\/j.pharep.2018.05.004_bib0030","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1001\/jama.2014.3654","article-title":"Pharmacological treatment of Parkinson disease: a review","volume":"311","author":"Connolly","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.pharep.2018.05.004_bib0035","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/(SICI)1099-1166(199909)14:9<711::AID-GPS4>3.0.CO;2-1","article-title":"Depression in patients with Parkinson's disease","volume":"14","author":"Cummings","year":"1999","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.pharep.2018.05.004_bib0040","doi-asserted-by":"crossref","first-page":"174S","DOI":"10.1592\/phco.27.12part2.174S","article-title":"Monoamine oxidase-B inhibition in the treatment of parkinson's disease","volume":"27","author":"Fernandez","year":"2007","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.pharep.2018.05.004_bib0045","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/S0140-6736(04)16305-8","article-title":"Parkinson's disease","volume":"363","author":"Samii","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.pharep.2018.05.004_bib0050","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/sj.bjp.0706464","article-title":"Monoamine oxidase: isoforms and inhibitors in Parkinson's disease and depressive illness","volume":"147","author":"Youdim","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharep.2018.05.004_bib0055","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.euroneuro.2005.12.002","article-title":"Dopaminergic-based pharmacotherapies for depression","volume":"16","author":"Papakostas","year":"2006","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pharep.2018.05.004_bib0060","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0140-6736(77)91940-7","article-title":"Implications of combined treatment with'madopar'and l-deprenil in parkinson's disease: a long-term study","volume":"309","author":"Birkmayer","year":"1977","journal-title":"Lancet"},{"key":"10.1016\/j.pharep.2018.05.004_bib0065","first-page":"289","article-title":"Clinical trial of a new type promptly acting psychoenergetic agent (phenyl-isopropyl-methylpropinyl-HCl, E-250)","volume":"23","author":"Varga","year":"1966","journal-title":"Acta Med Acad Sci Hung"},{"key":"10.1016\/j.pharep.2018.05.004_bib0070","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/0024-3205(80)90350-1","article-title":"L-Deprenyl a selective monoamine oxidase type-B inhibitor in endogenous depression","volume":"26","author":"Mann","year":"1980","journal-title":"Life Sci"},{"key":"10.1016\/j.pharep.2018.05.004_bib0075","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/BF01249880","article-title":"l-deprenyl plus l-phenylalanine in the treatment of depression","volume":"59","author":"Birkmayer","year":"1984","journal-title":"J Neural Transm"},{"key":"10.1016\/j.pharep.2018.05.004_bib0080","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1192\/bjp.142.5.508","article-title":"l-Deprenil a selective monoamine oxidase type B inhibitor, in the treatment of depression: a double blind evaluation","volume":"142","author":"Mendlewicz","year":"1983","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.pharep.2018.05.004_bib0085","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1001\/archpsyc.1984.01790190051006","article-title":"l-Deprenyl in atypical depressives","volume":"41","author":"Quitkin","year":"1984","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.pharep.2018.05.004_bib0090","first-page":"49","article-title":"Depression in Parkinson's disease: a biochemical and organic viewpoint","volume":"65","author":"Mayberg","year":"1995","journal-title":"Adv Neurol"},{"key":"10.1016\/j.pharep.2018.05.004_bib0095","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.euroneuro.2005.02.003","article-title":"Antidepressant-like effects of selegiline in the forced swim test","volume":"15","author":"Shimazu","year":"2005","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pharep.2018.05.004_bib0100","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0896-6273(95)90294-5","article-title":"Modulation of calcium currents by a D 1 dopaminergic protein kinase\/phosphatase cascade in rat neostriatal neurons","volume":"14","author":"Surmeier","year":"1995","journal-title":"Neuron"},{"key":"10.1016\/j.pharep.2018.05.004_bib0105","doi-asserted-by":"crossref","DOI":"10.1097\/00005344-199117003-00002","article-title":"The l-Arginine: nitric oxide pathway","volume":"17","author":"Moncada","year":"1991","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/j.pharep.2018.05.004_bib0110","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/0143-4160(92)90055-W","article-title":"Ca2+ calmodulin-regulated nitric oxide synthases","volume":"13","author":"Schmidt","year":"1992","journal-title":"Cell Calcium"},{"key":"10.1016\/j.pharep.2018.05.004_bib0115","first-page":"275","article-title":"Nitric oxide and its role in orthopaedic disease","volume":"312","author":"Evans","year":"1995","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/j.pharep.2018.05.004_bib0120","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/S0031-6997(25)06663-3","article-title":"Nitric oxide: physiology, pathophysiology, and pharmacology","volume":"43","author":"Moncada","year":"1991","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.pharep.2018.05.004_bib0125","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0304-4165(03)00005-9","article-title":"Decreased activity and impaired induction of nitric oxide synthase by lipopolysaccharides in streptozotocin-induced diabetic rats","volume":"1620","author":"Khandelwal","year":"2003","journal-title":"Biochim Biophys Acta (BBA)-Gen Subj"},{"key":"10.1016\/j.pharep.2018.05.004_bib0130","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/sj.bjp.0704569","article-title":"NO as a signalling molecule in the nervous system","volume":"135","author":"Esplugues","year":"2002","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.pharep.2018.05.004_bib0135","doi-asserted-by":"crossref","first-page":"11513","DOI":"10.1523\/JNEUROSCI.2259-06.2006","article-title":"Tonic and phasic nitric oxide signals in hippocampal long-term potentiation","volume":"26","author":"Hopper","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharep.2018.05.004_bib0140","doi-asserted-by":"crossref","first-page":"9344","DOI":"10.1523\/JNEUROSCI.1902-09.2009","article-title":"More than a retrograde messenger: nitric oxide needs two cGMP pathways to induce hippocampal long-term potentiation","volume":"29","author":"Taqatqeh","year":"2009","journal-title":"J Neurosci"},{"key":"10.1016\/j.pharep.2018.05.004_bib0145","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.pbb.2015.04.016","article-title":"Chloroquine-induced scratching is mediated by NO\/cGMP pathway in mice","volume":"134","author":"Foroutan","year":"2015","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharep.2018.05.004_bib0150","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.biopha.2016.10.068","article-title":"Evidence for the involvement of nitric oxide in cholestasis-induced itch associated response in mice","volume":"84","author":"Ostadhadi","year":"2016","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.pharep.2018.05.004_bib0155","doi-asserted-by":"crossref","first-page":"571","DOI":"10.2340\/00015555-2617","article-title":"Peripheral NMDA receptor\/NO system blockage inhibits itch responses induced by chloroquine in mice","volume":"97","author":"Haddadi","year":"2017","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.pharep.2018.05.004_bib0160","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.brainresbull.2015.11.020","article-title":"Possible involvement of nitrergic and opioidergic systems in the modulatory effect of acute chloroquine treatment on pentylenetetrazol induced convulsions in mice","volume":"121","author":"Hassanipour","year":"2016","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.pharep.2018.05.004_bib0165","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1097\/00001756-200011270-00022","article-title":"Evidence for dual effects of nitric oxide in the forced swimming test and in the tail suspension test in mice","volume":"11","author":"da Silva GdL. Matteussi","year":"2000","journal-title":"Neuroreport"},{"key":"10.1016\/j.pharep.2018.05.004_bib0170","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00210-015-1203-5","article-title":"Involvement of NO\/cGMP pathway in the antidepressant-like effect of gabapentin in mouse forced swimming test","volume":"389","author":"Ostadhadi","year":"2016","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.pharep.2018.05.004_bib0175","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejphar.2016.03.034","article-title":"Involvement of nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effect of tropisetron and ondansetron in mice forced swimming test and tail suspension test","volume":"780","author":"Haj-Mirzaian","year":"2016","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharep.2018.05.004_bib0180","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.neulet.2015.12.006","article-title":"The involvement of NMDA receptor\/NO\/cGMP pathway in the antidepressant like effects of baclofen in mouse force swimming test","volume":"612","author":"Khan","year":"2016","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharep.2018.05.004_bib0185","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.brainresbull.2016.03.004","article-title":"Involvement of NMDA receptors and l-arginine\/nitric oxide\/cyclic guanosine monophosphate pathway in the antidepressant-like effects of topiramate in mice forced swimming test","volume":"122","author":"Ostadhadi","year":"2016","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.pharep.2018.05.004_bib0190","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ejphar.2007.04.028","article-title":"Involvement of nitric oxide (NO) signaling pathway in the antidepressant action of bupropion, a dopamine reuptake inhibitor","volume":"568","author":"Dhir","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharep.2018.05.004_bib0195","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0091-3057(98)00011-2","article-title":"Comparison of behavioral effects of moclobemide and deprenyl during forced swimming","volume":"60","author":"Ferigolo","year":"1998","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.pharep.2018.05.004_bib0200","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.biopha.2016.05.035","article-title":"Pharmacological evidence for the involvement of the NMDA receptor and nitric oxide pathway in the antidepressant-like effect of lamotrigine in the mouse forced swimming test","volume":"82","author":"Ostadhadi","year":"2016","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/j.pharep.2018.05.004_bib0205","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.pharep.2016.07.006","article-title":"Possible involvement of ATP-sensitive potassium channels in the antidepressant-like effect of baclofen in mouse forced swimming test","volume":"68","author":"Nazari","year":"2016","journal-title":"Pharmacol Rep"},{"key":"10.1016\/j.pharep.2018.05.004_bib0210","first-page":"327","article-title":"Behavioral despair in mice: a primary screening test for antidepressants","volume":"229","author":"Porsolt","year":"1977","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"10.1016\/j.pharep.2018.05.004_bib0215","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/1440-1681.12518","article-title":"Involvement of opioid system in antidepressant-like effect of the cannabinoid CB1 receptor inverse agonist AM-251 after physical stress in mice","volume":"43","author":"Ostadhadi","year":"2016","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.pharep.2018.05.004_bib0220","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ejphar.2014.03.053","article-title":"Opioid\/NMDA receptors blockade reverses the depressant-like behavior of foot shock stress in the mouse forced swimming test","volume":"735","author":"Haj-Mirzaian","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharep.2018.05.004_bib0225","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1139\/cjpp-2016-0292","article-title":"Possible involvement of ATP-sensitive potassium channels in the antidepressant-like effects of gabapentin in mice forced swimming test","volume":"95","author":"Ostadhadi","year":"2017","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.pharep.2018.05.004_bib0230","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ejphar.2016.09.017","article-title":"The effect of nitrazepam on depression and curiosity in behavioral tests in mice: the role of potassium channels","volume":"791","author":"Nikoui","year":"2016","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharep.2018.05.004_bib0235","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1016\/j.pnpbp.2008.08.010","article-title":"Involvement of l-arginine?nitric oxide?cyclic guanosine monophosphate pathway in the antidepressant-like effect of tramadol in the rat forced swimming test","volume":"32","author":"Jesse","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.pharep.2018.05.004_bib0240","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ejphar.2007.08.045","article-title":"The antidepressant effects of curcumin in the forced swimming test involve 5-HT 1 and 5-HT 2 receptors","volume":"578","author":"Wang","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharep.2018.05.004_bib0245","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.euroneuro.2007.07.011","article-title":"Nitric oxide involvement in the antidepressant-like effects of acute lithium administration in the mouse forced swimming test","volume":"18","author":"Ghasemi","year":"2008","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pharep.2018.05.004_bib0250","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.euroneuro.2010.07.011","article-title":"Involvement of NMDA receptors and l-arginine-nitric oxide-cyclic guanosine monophosphate pathway in the antidepressant-like effects of escitalopram in the forced swimming test","volume":"20","author":"Zomkowski","year":"2010","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pharep.2018.05.004_bib0255","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.bbr.2011.06.011","article-title":"Antidepressant-like effect of pioglitazone in the forced swimming test in mice: the role of PPAR-gamma receptor and nitric oxide pathway","volume":"224","author":"Sadaghiani","year":"2011","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pharep.2018.05.004_bib0260","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ejphar.2015.06.030","article-title":"Elevated level of nitric oxide mediates the anti-depressant effect of rubidium chloride in mice","volume":"762","author":"Kordjazy","year":"2015","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharep.2018.05.004_bib0265","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0076-6879(96)68016-1","article-title":"Measurement of nitrate and nitrite in biological samples using nitrate reductase and Griess reaction","volume":"268","author":"Granger","year":"1996","journal-title":"Methods Enzymol"},{"key":"10.1016\/j.pharep.2018.05.004_bib0270","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0006-3223(93)90237-8","article-title":"Parkinson's disease and anxiety: comorbidity with depression","volume":"34","author":"Menza","year":"1993","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.pharep.2018.05.004_bib0275","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nrneurol.2010.49","article-title":"Parkinson disease: depression and anxiety in Parkinson disease","volume":"6","author":"Mart\u00ednez-Mart\u00edn","year":"2010","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.pharep.2018.05.004_bib0280","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1093\/brain\/awh445","article-title":"Depression in Parkinson's disease: loss of dopamine and noradrenaline innervation in the limbic system","volume":"128","author":"Remy","year":"2005","journal-title":"Brain"},{"key":"10.1016\/j.pharep.2018.05.004_bib0285","first-page":"4","article-title":"History and evolution of the monoamine hypothesis of depression","volume":"61","author":"Hirschfeld","year":"2000","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.pharep.2018.05.004_bib0290","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/0014-2999(93)90257-I","article-title":"Depletion of mesolimbic dopamine during behavioral despair: partial reversal by chronic imipramine","volume":"242","author":"Rossetti","year":"1993","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.pharep.2018.05.004_bib0295","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S0924-977X(00)00079-1","article-title":"The antidepressive-like effect of oxcarbazepine: possible role of dopaminergic neurotransmission","volume":"10","author":"Joca","year":"2000","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pharep.2018.05.004_bib0300","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s007020050151","article-title":"Pharmacological effects of venlafaxine, a new antidepressant, given repeatedly, on the \u03b11-adrenergic, dopamine and serotonin systems","volume":"106","author":"Maj","year":"1999","journal-title":"J Neural Transm"},{"key":"10.1016\/j.pharep.2018.05.004_bib0305","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2165\/00023210-199503020-00006","article-title":"Newer and older monoamine oxidase inhibitors","volume":"3","author":"Laux","year":"1995","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pharep.2018.05.004_bib0310","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.2147\/NDT.S49261","article-title":"selegiline remarkably improved stage 5 treatment-resistant major depressive disorder: a case report","volume":"9","author":"Kitaichi","year":"2013","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.pharep.2018.05.004_bib0315","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1089\/cap.2013.0138","article-title":"A double-blind, placebo-controlled study of selegiline transdermal system in depressed adolescents","volume":"24","author":"DelBello","year":"2014","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.pharep.2018.05.004_bib0320","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/BF02244374","article-title":"Role of genotype and dopamine receptors in behaviour of inbred mice in a forced swimming test","volume":"105","author":"Nikulina","year":"1991","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.pharep.2018.05.004_bib0325","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1124\/pr.110.002642","article-title":"The physiology, signaling, and pharmacology of dopamine receptors","volume":"63","author":"Beaulieu","year":"2011","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.pharep.2018.05.004_bib0330","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/j.neuron.2008.03.002","article-title":"D1 receptors physically interact with N-type calcium channels to regulate channel distribution and dendritic calcium entry","volume":"58","author":"Kisilevsky","year":"2008","journal-title":"Neuron"},{"key":"10.1016\/j.pharep.2018.05.004_bib0335","doi-asserted-by":"crossref","first-page":"269","DOI":"10.4161\/chan.2.4.6402","article-title":"D2 dopamine receptors interact directly with N-type calcium channels and regulate channel surface expression levels","volume":"2","author":"Kisilevsky","year":"2008","journal-title":"Channels"},{"key":"10.1016\/j.pharep.2018.05.004_bib0340","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1046\/j.1471-4159.1995.64020936.x","article-title":"Inhibition of neuronal nitric oxide synthase by 7-nitroindazole protects against MPTP-induced neurotoxicity in mice","volume":"64","author":"Schulz","year":"1995","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharep.2018.05.004_bib0345","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1046\/j.1471-4159.1998.70062510.x","article-title":"(\u2212)-Deprenyl protects human dopaminergic neuroblastoma SH-SY5Y cells from apoptosis induced by peroxynitrite and nitric oxide","volume":"70","author":"Maruyama","year":"1998","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharep.2018.05.004_bib0350","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.1471-4159.1997.68010033.x","article-title":"l-Deprenyl protects mesencephalic dopamine neurons from glutamate receptor-mediated toxicity In vitro","volume":"68","author":"Mytilineou","year":"1997","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharep.2018.05.004_bib0355","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1111\/j.1471-4159.1993.tb03278.x","article-title":"Excitatory amino acid-mediated cytotoxicity and calcium homeostasis in cultured neurons","volume":"60","author":"Frandsen","year":"1993","journal-title":"J Neurochem"},{"key":"10.1016\/j.pharep.2018.05.004_bib0360","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/0304-3940(91)90147-L","article-title":"NMDA receptor activation in rat hippocampus induces cyclic GMP formation through the l-arginine-nitric oxide pathway","volume":"123","author":"East","year":"1991","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.pharep.2018.05.004_bib0365","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/eurheartj\/ehr304","article-title":"Nitric oxide synthases: regulation and function","volume":"33","author":"F\u00f6rstermann","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/j.pharep.2018.05.004_bib0370","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0166-4328(02)00084-0","article-title":"Reduction of cGMP and nitric oxide has antidepressant-like effects in the forced swimming test in rats","volume":"134","author":"Heiberg","year":"2002","journal-title":"Behav Brain Res"},{"key":"10.1016\/j.pharep.2018.05.004_bib0375","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.euroneuro.2003.08.010","article-title":"Nitric oxide synthase inhibitors augment the effects of serotonin re-uptake inhibitors in the forced swimming test","volume":"14","author":"Harkin","year":"2004","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.pharep.2018.05.004_bib0380","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1146\/annurev.neuro.23.1.185","article-title":"Dopaminergic modulation of neuronal excitability in the striatum and nucleus accumbens","volume":"23","author":"Nicola","year":"2000","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.pharep.2018.05.004_bib0385","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/S0005-2728(99)00024-9","article-title":"Guanylate cyclase and the NO\/cGMP signaling pathway","volume":"1411","author":"Denninger","year":"1999","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.pharep.2018.05.004_bib0390","first-page":"417","article-title":"The role of the hippocampus in the pathophysiology of major depression","volume":"29","author":"Campbell","year":"2004","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/j.pharep.2018.05.004_bib0395","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0306-4522(03)00217-3","article-title":"Species, strain and developmental variations in hippocampal neuronal and endothelial nitric oxide synthase clarify discrepancies in nitric oxide-dependent synaptic plasticity","volume":"119","author":"Blackshaw","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.pharep.2018.05.004_bib0400","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2014.01.030","article-title":"The pattern of glutamate-induced nitric oxide dynamics in vivo and its correlation with nNOS expression in rat hippocampus, cerebral cortex and striatum","volume":"1554","author":"Louren\u00e7o","year":"2014","journal-title":"Brain Res"}],"container-title":["Pharmacological Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114017302608?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1734114017302608?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:37:40Z","timestamp":1752611860000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1016\/j.pharep.2018.05.004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":80,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S1734114017302608"],"URL":"https:\/\/doi.org\/10.1016\/j.pharep.2018.05.004","relation":{},"ISSN":["1734-1140"],"issn-type":[{"value":"1734-1140","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of nitric oxide\u2013cGMP pathway in selegiline antidepressant-like effect in the mice forced swim test","name":"articletitle","label":"Article Title"},{"value":"Pharmacological Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharep.2018.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Institute of Pharmacology, Polish Academy of Sciences. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}